If your child's glasses prescription climbs a little stronger every year, you are not imagining it, and you are right to act. Childhood myopia (nearsightedness) tends to progress fastest during the school years, and the faster it advances, the higher your child's lifetime risk of serious eye problems such as retinal detachment, glaucoma, and myopic macular degeneration. The encouraging news is that progression can be slowed. At Mudgil Eye Associates, right here in West Chester, we build a personalized myopia control plan for each child using MiSight 1 day contact lenses, which are FDA-approved to slow myopia progression, and low-dose atropine, guided by a Johns Hopkins fellowship-trained pediatric ophthalmologist working alongside a residency-trained pediatric optometrist.
Families from West Chester, East Goshen, Westtown, and the surrounding Chester County communities come to us because myopia control is not a single product; it is a plan that is measured, adjusted, and monitored over years. Between screen-heavy classrooms, homework, and less time outdoors than previous generations spent, more children than ever are becoming nearsighted at younger ages. Our team helps you get ahead of it, and because we are a complete MD-and-OD practice, everything your child's eyes might need is already under one roof.
MiSight is an FDA-approved daily contact lens proven to slow the progression of myopia in children. Your child wears it during the day, and it both corrects vision and helps keep the prescription from climbing as quickly. We are listed on the manufacturer's official provider locator.
Dr. A. Vijay Mudgil completed his pediatric ophthalmology fellowship at the Wilmer Eye Institute at Johns Hopkins, and Dr. Reetu Julakanti provides residency-trained pediatric optometric care. Your child's myopia plan is overseen by pediatric eye specialists who do this every day.
For children who are not ready for contact lenses, we also offer low-dose atropine eye drops, a simple nightly drop widely used to help slow myopia progression. We help you choose the approach that fits your child best, and some children do well with a combination.
We are a complete practice with both a pediatric optometrist and a fellowship-trained pediatric ophthalmologist working side by side. Optometrists are central to children's vision care, and pairing that expertise with an on-site pediatric ophthalmologist means that if your child ever needs more than myopia control, that care is already in place.
Myopia, or nearsightedness, is more than a blurry view of the whiteboard. In a nearsighted eye, the eyeball has grown slightly too long from front to back, a change called axial elongation. Because the eye is too long, light from distant objects focuses just in front of the retina instead of directly on it, so far-away things look blurry while near objects stay clear. Glasses and standard contacts bend light to clear up that blur, but they do not change the underlying length of the eye or slow how fast it is growing. That is the job of myopia control.
The goal of myopia control is not simply a thinner lens at the next visit. Each additional increment of nearsightedness means a slightly longer, more stretched eye, and a higher lifetime risk of conditions such as retinal detachment, glaucoma, earlier cataract, and myopic maculopathy in adulthood. By slowing how quickly a child's myopia progresses during the growing years, we aim to keep their final adult prescription lower than it would otherwise be, which lowers those long-term risks. Myopia control does not cure or reverse nearsightedness that is already present, and results vary from child to child, but for most children it meaningfully slows progression.
Childhood myopia is rising worldwide, and Chester County is no exception. Genetics play a large role, so a child with one or two nearsighted parents is more likely to become nearsighted, but environment matters too. Long hours of close work, reading, homework, and screens, combined with less time spent outdoors in natural light, are associated with faster progression. One of the simplest, evidence-supported steps any West Chester family can take is to protect regular outdoor time, which is why we talk about daily habits alongside any lens or drop.
For many West Chester children who are ready to handle a contact lens, MiSight 1 day is a compelling first choice. It is the only soft contact lens approved by the FDA specifically to slow the progression of myopia in children, and because it is a daily-disposable lens worn during the day, it also corrects your child's distance vision while it is worn. Many families find that convenient on the soccer field or in class, and results vary from child to child.
A MiSight lens looks and feels like an ordinary soft contact lens, but it is designed with concentric treatment zones. The central zone corrects distance vision clearly, while the surrounding zones focus part of the light slightly in front of the peripheral retina, a signal that appears to slow the eye's tendency to elongate. In the manufacturer's multi-year clinical study, children wearing MiSight had substantially slower myopia progression on average than children in a control group, roughly a 59 percent reduction in the rate of progression over three years. That figure is a clinical-study finding, and individual results vary from child to child.
MiSight tends to suit school-age and older children, often around ages 8 to 12 at the start, who are motivated and responsible enough to insert, remove, and care for a lens with a parent's help at first. Because it is a fresh lens every day, there is no cleaning solution or storage case to manage. Children with significant astigmatism may not be ideal candidates, which is one of the things Dr. Julakanti evaluates at the fitting. For the lenses to do their job, they are worn most waking hours, generally at least 10 hours a day, six or more days a week, until the eyes stop growing and the prescription stabilizes.
Parents in West Chester frequently ask us about a treatment that does not require their child to handle a contact lens at all: a small drop placed in each eye at bedtime. Low-dose atropine has become one of the most discussed approaches to slowing childhood myopia, and for the right child it can be a straightforward and well-tolerated option. Our office is right here in West Chester, and an atropine consultation is a common reason local families come to see us.
Atropine is a long-established eye medication. At the very low concentrations used for myopia control, commonly between 0.01% and 0.05%, it is used off-label to slow the elongation of a child's eye over time. This is a different purpose and a far weaker strength than the dilating drops used during a comprehensive eye exam, which is why the everyday side effects most people associate with atropine are usually minimal at these low doses.
The appeal for many West Chester parents is the simplicity. A single drop is placed in each eye at night, often as part of the bedtime routine, and the child wears their normal glasses during the day. There are no lenses to insert, clean, or store. Because the dose is low, many children notice little to no change in how their eyes feel, though some may experience slight light sensitivity or a small effect on close focus, which we monitor and can adjust for by changing the concentration.
One reason atropine works well as a managed, primary treatment is that the strength can be tailored. We may begin at a lower concentration and adjust based on how a child's prescription responds over the following months. This is not a set-and-forget medication; it is a plan that our optometric team revisits at follow-up visits, watching both the rate of progression and how comfortably the child tolerates the drop.
Atropine is one of two evidence-based tools we use, and occasionally they are combined. MiSight 1 day contact lenses, FDA-approved to slow progression in children roughly ages 8 to 12, suit families comfortable with daily lens wear. Atropine often becomes the lead choice for younger children, for kids not yet ready for contacts, or for families who simply prefer a drop. Slowing progression with either method matters because higher myopia carries a greater lifetime risk of retinal detachment, glaucoma, and myopic maculopathy.
Both MiSight 1 day contact lenses and low-dose atropine drops are proven, evidence-based ways to slow how quickly a child's nearsightedness progresses. Neither cures myopia, and neither works identically for every child, so the right choice depends on your child, not on a one-size-fits-all protocol. The factors we weigh together include your child's age and maturity, their current prescription and how fast it is changing, whether they are comfortable with a contact lens, their degree of astigmatism, their activities, and your family's preferences.
In general, MiSight suits an older, contact-lens-ready child who is comfortable wearing a lens during the day, while low-dose atropine suits a younger child, a child not yet ready for lenses, or a family that prefers a simple nightly drop with glasses worn by day. Some children start with one approach and switch later as they grow, and in selected cases the two can be combined. Whichever path we choose, myopia control is a managed plan: we measure your child's prescription, and where helpful the length of the eye, at regular visits, and we adjust the plan over time. Results vary from child to child, and our aim is the best possible outcome for yours.
The best time to begin myopia control is early in the progression, while the eye is still growing and there is more change left to prevent. In practice, that often means the first time a child needs glasses for distance, or the first time a prescription jumps between annual exams. Myopia most commonly appears between about ages 8 and 12, but it can start earlier, and children with nearsighted parents or a fast-changing prescription deserve a closer look sooner rather than later. You do not need a referral to schedule an evaluation.
Most nearsighted children are candidates for some form of myopia control. The clearest signals that it is time to ask us include a prescription that increases at each visit, squinting or sitting close to the board or television, frequent headaches or eye strain, or a family history of high myopia. The only way to know which treatment fits is a comprehensive evaluation, and part of our job is to tell you plainly whether myopia control is likely to help your child and which option makes the most sense.
A myopia control evaluation is a thorough pediatric eye exam, not a quick screening. We measure your child's vision and full prescription, often using dilating drops for accuracy, check eye alignment and overall eye health, and take baseline measurements so we can track progression precisely over time. Then we sit down with you and your child, explain the findings in plain language, and lay out the options, including what each treatment involves day to day, what it can and cannot do, and the follow-up schedule. If a contact lens is the plan, we fit it and teach your child how to handle it. Plan for the visit to take a little longer than a comprehensive eye exam, especially if drops are used.
Myopia management works best as a long-term relationship, and at Mudgil Eye Associates your child has an unusually complete team. Dr. Reetu R. Julakanti, our residency-trained pediatric optometrist, leads the day-to-day myopia control program, fitting MiSight lenses, prescribing and adjusting low-dose atropine, and tracking each child's progress across the years of treatment. Optometrists are the backbone of children's vision care, and Dr. Julakanti's focused pediatric training is exactly what a growing, changing prescription calls for.
Working alongside her is Dr. A. Vijay Mudgil, a board-certified, fellowship-trained pediatric ophthalmologist who completed his pediatric ophthalmology and strabismus fellowship at the Wilmer Eye Institute at Johns Hopkins and has cared for Chester County families for more than 20 years. He has been named a Main Line Today Top Doctor since 2009. Having both an optometrist and a fellowship-trained pediatric ophthalmologist in the same practice means that if your child ever needs more than myopia control, from a difficult prescription to eye misalignment or a medical concern, that expertise is already part of their care team, with no new referral and no starting over.
Learn more about our pediatric eye care for children of all ages, or explore our full myopia management program for Chester County families.
Yes. Dr. Reetu Julakanti, our pediatric optometrist, fits FDA-approved MiSight 1 day contact lenses for children in the West Chester area. MiSight is a soft daily-disposable lens worn during the day that corrects vision and is proven to slow the progression of myopia in children.
Both are proven, evidence-based ways to slow how fast a child's nearsightedness progresses. MiSight suits an older child ready to handle a daily contact lens; low-dose atropine, a simple nightly eye drop, suits younger children or those not ready for contacts. Dr. Julakanti helps you choose and adjusts the plan over time.
Myopia control combines proven treatments, MiSight 1 day contact lenses and low-dose atropine, with lifestyle steps like more time outdoors. West Chester-area families see Dr. Julakanti, who builds a plan for each child and monitors progress at regular visits. Slowing progression matters because higher myopia raises the lifetime risk of eye problems later in life.
Myopia control is most effective when it begins early in the progression, while the eye is still growing. Most children start between about ages 6 and 12, often at the first sign that a prescription is increasing, but there is no single right age. Because the goal is to prevent future change, starting sooner generally means a lower final prescription. If your child is newly nearsighted or their prescription is climbing, it is worth an evaluation now rather than waiting.
No. Myopia control does not cure nearsightedness or reverse the prescription your child already has. Its purpose is to slow how quickly myopia progresses during the growing years, so your child's eyes end up less nearsighted than they otherwise would. Your child will still wear glasses or contacts to see clearly, and results vary from child to child.
Neither is universally better; the right choice depends on your child. MiSight 1 day contact lenses suit an older, contact-lens-ready child who is comfortable wearing a lens during the day. Low-dose atropine, a simple nightly drop with glasses worn by day, suits younger children or those not ready for contacts. Both are evidence-based and proven to slow progression. Dr. Julakanti helps you choose based on your child's age, prescription, comfort with lenses, and lifestyle, and adjusts the plan over time.
Yes. Many families find myopia control fits active kids well. MiSight 1 day lenses are worn during the day and correct distance vision while they are worn, which many children prefer for sports, and each lens is discarded at the end of the day. Low-dose atropine is a nighttime drop, so it does not interfere with daytime activities at all; the child simply wears their regular glasses or sports eyewear. We are happy to talk through protective eyewear for your child's specific sport. Results vary from child to child.
For most children, myopia control meaningfully slows the rate of progression, though it does not stop it completely or reverse existing nearsightedness. In its multi-year clinical study, MiSight was associated with roughly a 59 percent reduction in the rate of myopia progression over three years, and low-dose atropine has been shown in multiple studies to slow progression as well. These are clinical-study findings; how much any individual child benefits varies, which is why we monitor progress and adjust the plan at regular visits.
Myopia control usually continues through the growing years, until a child's eyes stop changing and the prescription stabilizes, which is often in the mid-to-late teens or early adulthood. Stopping is something to plan with us rather than do abruptly, and we guide the timing based on how your child's eyes are behaving. Regular follow-up visits are part of the plan throughout.
Low-dose atropine is used off-label for myopia control; the low concentrations used, commonly 0.01 to 0.05 percent, have a long track record in eye care and are generally very well tolerated. MiSight, by contrast, is FDA-approved specifically for slowing myopia progression in children. Most children on low-dose atropine have no side effects; a small number notice mild light sensitivity or a slight effect on near focus, which we can manage by adjusting the concentration.
You do not need a referral to schedule a myopia evaluation. Coverage for myopia control varies by plan, and some services or materials may not be covered by medical insurance, so our team will review the details with you before treatment begins. Call our West Chester office at (610) 429-3004 and we will help you understand your options.
Most West Chester families are seen within one to two weeks for an initial myopia evaluation. Call 610-429-3004 or schedule online, and we will help you get ahead of your child's nearsightedness.